Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endobronchial ultrasound transbronchial needle aspiration in older people.
Okachi S, Imai N, Imaizumi K, Hase T, Shindo Y, Sakamoto K, Aso H, Wakahara K, Hashimoto I, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y. Okachi S, et al. Among authors: hase t. Geriatr Gerontol Int. 2013 Oct;13(4):986-92. doi: 10.1111/ggi.12043. Epub 2013 Mar 6. Geriatr Gerontol Int. 2013. PMID: 23461485
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
Shi H, Niimi A, Takeuchi T, Shiogama K, Mizutani Y, Kajino T, Inada K, Hase T, Hatta T, Shibata H, Fukui T, Chen-Yoshikawa TF, Nagano K, Murate T, Kawamoto Y, Tomida S, Takahashi T, Suzuki M. Shi H, et al. Among authors: hase t. Cancer Sci. 2021 Jul;112(7):2770-2780. doi: 10.1111/cas.14928. Epub 2021 May 4. Cancer Sci. 2021. PMID: 33934437 Free PMC article.
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Yamamoto T, Ito T, Hase T, Ishigami M, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Shibata H, Hatta T, Yogo N, Yasuda S, Toyoda H, Abe T, Kawashima H, Hashimoto N, Fujishiro M. Yamamoto T, et al. Among authors: hase t. Cancer Invest. 2022 Feb;40(2):189-198. doi: 10.1080/07357907.2021.1994586. Epub 2021 Nov 29. Cancer Invest. 2022. PMID: 34658277
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR.
Matsuzawa R, Morise M, Kinoshita F, Tanaka I, Koyama J, Kimura T, Kondoh Y, Tanaka T, Shima K, Hase T, Wakahara K, Ishii M, Hashimoto N. Matsuzawa R, et al. Among authors: hase t. J Cancer Res Clin Oncol. 2023 Jul;149(7):3885-3893. doi: 10.1007/s00432-022-04300-x. Epub 2022 Aug 25. J Cancer Res Clin Oncol. 2023. PMID: 36006483
594 results